Brighton Jones’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Brighton Jones's BMRN Position: Q3 2026 in Review
Brighton Jones reduced its BioMarin Pharmaceuticals (BMRN) stake by 3.6% in Q3 2026, selling an estimated $39.1K and leaving 16,625 shares worth $997K. The position accounts for 0.02% of the portfolio, ranked #526.
Brighton Jones first reported a position in BMRN in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.57M in Q1 2026. 443 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Brighton Jones held 16,625 shares of BioMarin Pharmaceuticals worth $997K as of Q3 2026.
- Brighton Jones sold 621 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $39.1K.
- BioMarin Pharmaceuticals made up 0.02% of Brighton Jones's portfolio in Q3 2026, its #526 holding.
- Brighton Jones first reported a position in BioMarin Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- Brighton Jones's BioMarin Pharmaceuticals position peaked at $1.57M in Q1 2026.
- 443 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.